{
    "organizations": [],
    "uuid": "b76e9c0820c4979ef2ecdd4a3a00369e4254ab4b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-moleculin-biotech-reports-financia/brief-moleculin-biotech-reports-financial-results-for-the-year-ended-dec-31-2017-idUSASC09TYW",
    "ord_in_thread": 0,
    "title": "BRIEF-Moleculin Biotech Reports Financial Results For The Year Ended Dec 31, 2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - Moleculin Biotech Inc:\n* MOLECULIN BIOTECH, INC. REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2017\n* MOLECULIN BIOTECH - BELIEVES EXISTING CASH & CASH EQUIVALENTS AS OF DECEMBER 31, 2017, OTHER CASH, WILL BE SUFFICIENT TO FUND PLANNED OPERATIONS INTO Q1 2019 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-28T21:05:00.000+03:00",
    "crawled": "2018-03-29T15:57:10.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "moleculin",
        "biotech",
        "inc",
        "moleculin",
        "biotech",
        "report",
        "financial",
        "result",
        "year",
        "ended",
        "december",
        "moleculin",
        "biotech",
        "belief",
        "existing",
        "cash",
        "cash",
        "equivalent",
        "december",
        "cash",
        "sufficient",
        "fund",
        "planned",
        "operation",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}